Novartis has a rich history of over 130 years in Russia, exemplifying its commitment to the local market. In 2010, the company announced a strategic investment initiative aimed at enhancing the Russian healthcare landscape through local production, advancing scientific research, and improving healthcare systems. As a leading global healthcare company, Novartis specializes in innovative medicines designed to address complex health challenges across various therapeutic areas, including oncology, hematology, cardiology, and immunology.

Their product portfolio features cutting-edge therapies that cater to the evolving needs of patients, emphasizing their mission to improve the quality and longevity of life through scientific innovation. Novartis fosters a strong cultural foundation based on values of inspiration, ethics, curiosity, and Unbossed leadership. Committed to social responsibility, they engage actively with healthcare professionals and patient organizations, dedicating resources to ensure accessible healthcare solutions. Overall, Novartis plays a pivotal role in the ongoing evolution of healthcare in Russia, striving for a healthier future for all.